274 related articles for article (PubMed ID: 37175866)
21. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
Wujek JR; Bjartmar C; Richer E; Ransohoff RM; Yu M; Tuohy VK; Trapp BD
J Neuropathol Exp Neurol; 2002 Jan; 61(1):23-32. PubMed ID: 11829341
[TBL] [Abstract][Full Text] [Related]
22. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
[TBL] [Abstract][Full Text] [Related]
23. Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Durose WW; Shimizu T; Li J; Abe M; Sakimura K; Chetsawang B; Tanaka KF; Suzumura A; Tohyama K; Ikenaka K
J Neurochem; 2019 Feb; 148(3):413-425. PubMed ID: 30152001
[TBL] [Abstract][Full Text] [Related]
24. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice.
Morris-Downes MM; Smith PA; Rundle JL; Piddlesden SJ; Baker D; Pham-Dinh D; Heijmans N; Amor S
J Neuroimmunol; 2002 Apr; 125(1-2):114-24. PubMed ID: 11960647
[TBL] [Abstract][Full Text] [Related]
25. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.
Miller SD; Gerety SJ; Kennedy MK; Peterson JD; Trotter JL; Tuohy VK; Waltenbaugh C; Dal Canto MC; Lipton HL
J Neuroimmunol; 1990 Jan; 26(1):9-23. PubMed ID: 1688446
[TBL] [Abstract][Full Text] [Related]
26. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
[TBL] [Abstract][Full Text] [Related]
27. Anti-Glycolipid Antibody Examination in Five EAE Models and Theiler's Virus Model of Multiple Sclerosis: Detection of Anti-GM1, GM3, GM4, and Sulfatide Antibodies in Relapsing-Remitting EAE.
Moriguchi K; Nakamura Y; Park AM; Sato F; Kuwahara M; Khadka S; Omura S; Ahmad I; Kusunoki S; Tsunoda I
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629117
[TBL] [Abstract][Full Text] [Related]
28. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
[TBL] [Abstract][Full Text] [Related]
29. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
30. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
[TBL] [Abstract][Full Text] [Related]
31. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
32. Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis.
Mathisen PM; Kawczak JA; Yu M; Johnson JM; Tuohy VK
J Neurosci Res; 2001 Jun; 64(5):542-51. PubMed ID: 11391709
[TBL] [Abstract][Full Text] [Related]
33. Novel monoclonal antibodies against proteolipid protein peptide 139-151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesions.
Laman JD; Visser L; Maassen CB; de Groot CJ; de Jong LA; 't Hart BA; van Meurs M; Schellekens MM
J Neuroimmunol; 2001 Sep; 119(1):124-30. PubMed ID: 11525809
[TBL] [Abstract][Full Text] [Related]
34. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.
Lorentzen JC; Issazadeh S; Storch M; Mustafa MI; Lassman H; Linington C; Klareskog L; Olsson T
J Neuroimmunol; 1995 Dec; 63(2):193-205. PubMed ID: 8550817
[TBL] [Abstract][Full Text] [Related]
35. Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS).
Constantinescu CS; Lavi E
Curr Eye Res; 2000 Jan; 20(1):71-6. PubMed ID: 10611718
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive visual evoked potentials to assess optic nerve involvement in the dark agouti rat model of experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein.
Castoldi V; Marenna S; d'Isa R; Huang SC; De Battista D; Chirizzi C; Chaabane L; Kumar D; Boschert U; Comi G; Leocani L
Brain Pathol; 2020 Jan; 30(1):137-150. PubMed ID: 31267597
[TBL] [Abstract][Full Text] [Related]
37. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
[TBL] [Abstract][Full Text] [Related]
38. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
39. Effects of exercise in a relapsing-remitting model of experimental autoimmune encephalomyelitis.
Klaren RE; Stasula U; Steelman AJ; Hernandez J; Pence BD; Woods JA; Motl RW
J Neurosci Res; 2016 Oct; 94(10):907-14. PubMed ID: 27312674
[TBL] [Abstract][Full Text] [Related]
40. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
Yu M; Johnson JM; Tuohy VK
J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
